A vs AZTA
A: Agilent Technologies provides essential laboratory instruments, software, and services that power scientific discovery and clinical diagnostics. AZTA: Azenta provides critical sample management and automated cold storage solutions that underpin life sciences research and clinical development.
Side-by-side fundamentals
| Metric | A | AZTA | Edge |
|---|---|---|---|
| Price as of 2026-10-21 close | $177.75 | $36.76 | |
| Market cap | $50.1B | $1.6B | |
| P/E as of 2026-10-21 | 35.06 | n/a | |
| PEG as of 2026-10-21, 3-year EPS CAGR to FY2025 | 11.62 | n/a | |
| Net margin FY2025, SEC XBRL | +18.8% | -9.4% | A higher |
| Gross margin FY2025, SEC XBRL | n/a | +45.5% | |
| Operating margin FY2025, SEC XBRL | +21.3% | -4.5% | A higher |
| ROE FY2025, SEC XBRL | +19.3% | -3.3% | A higher |
| ROA FY2025, SEC XBRL | +10.2% | -2.7% | A higher |
| Debt / equity filed borrowings, leases excl., balance sheet 2026-07-31 | 0.54 | n/a | |
| Revenue growth (YoY) FY2025, SEC XBRL | +6.7% | +3.5% | A higher |
| Revenue CAGR (3y) SEC XBRL | +0.5% | +2.2% | AZTA higher |
| Dividend yield as of 2026-09-03 | +0.7% | n/a | |
| Dividend streak (yrs) SEC XBRL | 11 | 1 | A higher |
| Beta as of 2026-09-03 | 0.96 | 1.38 | |
| 1-year return as of 2026-10-21 close | +22.0% | +15.6% | A higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.